These guidelines deal with the evaluation of anti-infective drugs for the treatment of
respiratory tract infections. Five clinical entities are described: streptococcal pharyngitis and …

The present report constitutes an attempt to improve and modify the existing clinical
evaluation method for new antimicrobial agents to treat respiratory infections. One year ago …

Methods We conducted a cross-sectional survey of patients presenting with nonemergent
upper respiratory infection-type symptoms to two University of Virginia outpatient clinics that …

Objectives: To foster the appropriate use of antimicrobial agents for respiratory tract
infections and to review factors that should help achieve this objective. Study Design …

Penicillin has been the recommended drug of choice in most cases of group A streptococcus
(GAS) pharyngitis for nearly 40 years based on its efficacy in the prevention of acute …

Abstract In the United States, drug sponsors must obtain approval from the US Food and
Drug Administration before licensure and widespread clinical use of drugs. In this article, I …

Evidence from studies in otitis media, acute bacterial sinusitis and acute exacerbations of
chronic bronchitis indicate that clinical efficacy is dependent on bacterial eradication. Failure …

Objectives: The aim of this paper is to review the four Cochrane reviews of antibiotics for
upper respiratory tract infections. Methods: Each Cochrane review was read and …

This clinically orientated book aims to deal with issues related to respiratory tract infections,
providing a practical management approach to common clinical conditions. The 5 chapters …

Acute bronchitis is usually a viral infection which, unless there is a special disposition, does
not require antibiotic therapy. For the initial oral chemotherapy of bacterial infections of the …